[Form 4] Weyco Group Inc Insider Trading Activity
Joshua Wisenthal, President of Weyco Canada and a director/officer of Weyco Group Inc. (WEYS), reported a transaction dated 08/25/2025 in which 1,375 shares of WEYS common stock were acquired at a reported price of $0, increasing his beneficial ownership to 7,450 shares. The Form 4 also lists outstanding stock options exercisable into common stock: seven option grants ranging from 1,000 to 2,500 underlying shares with exercise prices from $18.00 to $37.22 and expiration dates in 2027–2033. Each option grant carries a vesting schedule noted as 20% per year for 5 years from the listed grant date. The filing is signed 08/27/2025.
- 1,375 shares vested, increasing the reporting person’s direct ownership to 7,450 shares
- Multiple outstanding option grants with staggered vesting (20% per year for 5 years) support retention incentives
- Option expirations extend to 2033, indicating long-term alignment of compensation with company performance
- None.
Insights
TL;DR: Insider received vested shares, modestly increasing direct ownership; multiple long-dated options remain outstanding with staged vesting.
The 08/25/2025 acquisition of 1,375 shares at $0 appears as shares delivered on vesting rather than an open-market purchase, bringing total beneficial ownership to 7,450 shares. The disclosed option schedule shows seven grants with staggered vesting (20% per year over five years) and expirations through 2033, indicating ongoing equity compensation. This is a routine insider compensation event rather than a market-transacting purchase or sale; it does not itself provide directional information about company performance but changes the insider's direct share count and option overhang.
TL;DR: Filing documents routine equity-based compensation vesting; retention-focused vesting schedules maintained across multiple grants.
The Form 4 documents vesting-produced share acquisition and a consistent set of option grants with identical 20% annual vesting for five years, suggesting a standardized compensation policy for this officer. The exercise prices and long expirations align with typical incentive awards. The report is complete for the transactions shown and is appropriately signed and dated, fulfilling Section 16 reporting obligations.